Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2008-2-25
pubmed:abstractText
We examined the correlation between HER2 expression and pathologic complete response (pCR) to paclitaxel/FAC (T/FAC) preoperative chemotherapy in breast cancer.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Neoplasm, http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide, http://linkedlifedata.com/resource/pubmed/chemical/DNA Topoisomerases, Type II, http://linkedlifedata.com/resource/pubmed/chemical/DNA topoisomerase II alpha, http://linkedlifedata.com/resource/pubmed/chemical/DNA-Binding Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Doxorubicin, http://linkedlifedata.com/resource/pubmed/chemical/ERBB2 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Fluorouracil, http://linkedlifedata.com/resource/pubmed/chemical/MAPT protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Paclitaxel, http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger, http://linkedlifedata.com/resource/pubmed/chemical/Receptor, erbB-2, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Estrogen, http://linkedlifedata.com/resource/pubmed/chemical/tau Proteins
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0167-6806
pubmed:author
pubmed:issnType
Print
pubmed:volume
108
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
183-90
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:17468948-Antigens, Neoplasm, pubmed-meshheading:17468948-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:17468948-Breast Neoplasms, pubmed-meshheading:17468948-Cyclophosphamide, pubmed-meshheading:17468948-DNA Topoisomerases, Type II, pubmed-meshheading:17468948-DNA-Binding Proteins, pubmed-meshheading:17468948-Disease-Free Survival, pubmed-meshheading:17468948-Doxorubicin, pubmed-meshheading:17468948-Drug Administration Schedule, pubmed-meshheading:17468948-Female, pubmed-meshheading:17468948-Fluorouracil, pubmed-meshheading:17468948-Gene Amplification, pubmed-meshheading:17468948-Gene Expression Profiling, pubmed-meshheading:17468948-Gene Expression Regulation, Neoplastic, pubmed-meshheading:17468948-Humans, pubmed-meshheading:17468948-Middle Aged, pubmed-meshheading:17468948-Neoadjuvant Therapy, pubmed-meshheading:17468948-Neoplasm Staging, pubmed-meshheading:17468948-Oligonucleotide Array Sequence Analysis, pubmed-meshheading:17468948-Paclitaxel, pubmed-meshheading:17468948-Patient Selection, pubmed-meshheading:17468948-RNA, Messenger, pubmed-meshheading:17468948-Receptor, erbB-2, pubmed-meshheading:17468948-Receptors, Estrogen, pubmed-meshheading:17468948-Retrospective Studies, pubmed-meshheading:17468948-Time Factors, pubmed-meshheading:17468948-Treatment Outcome, pubmed-meshheading:17468948-tau Proteins
pubmed:year
2008
pubmed:articleTitle
HER2 expression and efficacy of preoperative paclitaxel/FAC chemotherapy in breast cancer.
pubmed:affiliation
Breast Cancer Unit, Institut Gustave Roussy, Villejuif, France.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural